Bistos
비스토스 · 419540
Health Care Medical Devices · KOSDAQ
Market cap US$8.9M (₩12.3B)
Overview
Bistos makes medical devices that monitor and care for unborn babies and newborns, including fetal heartbeat monitors, jaundice treatment units, and infant incubators, as well as breast pumps and general patient-monitoring equipment for broader clinical and home use.
Its products reach hospitals, clinics, and consumers across a wide range of countries, with the vast majority of its revenue coming from exports. Listed on KOSDAQ, Korea's tech and small-cap board, the company derives most of its sales from fetal and neonatal devices, though it has been steadily expanding into home-use and general medical equipment.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$15.4M
- FY2024US$14.7M
- FY2025US$12.4M
Operating profit
- FY2023US$205.7K
- FY2024US$225.7K
- FY2025−US$793.9K
Net income
- FY2023US$584.4K
- FY2024US$614.2K
- FY2025−US$506.6K
Key ratios (FY2025)
Why it matters
Bistos describes itself as the sole domestic Korean supplier of fetal heartbeat monitors, supplying them directly to expectant mothers as well as to medical facilities.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?